In type 1 diabetes (T1D), a Toll-like receptor (TLR)-hyper-inflammatory monocytic phenotype has been implicated as a mechanism of exacerbated tissue destruction. Other cells of the periodontium, including oral epithelial cells (OECs), express innate immune receptors, including TLRs. To delineate the TLR responses of OECs derived from T1D participants and to determine effects of the anti-inflammatory agent triclosan on the TLRhyper-inflammatory phenotype, primary human OECs from individuals with T1D and diabetesfree individuals were stimulated with TLR ligands in the presence and/or absence of triclosan. The expression of pro-inflammatory cytokines and micro-RNAs (miRNAs) was evaluated. While the repertoire of TLRs expressed by OECs is similar to that expressed by macrophages (Mϕ), the relative amounts and ratios are significantly different. OECs demonstrate a TLR-response profile similar to that of Mϕ, yet attenuated. OECs have a unique response to P. gingivalis LPS, where miR146a and miR155 play a regulatory role in responsiveness. OECs from T1D participants are TLR-hyperresponsive, due to dysregulated induction of miR146a and miR155, which is abrogated by pretreatment with triclosan. The aberrant TLRactivation of OECs in T1D has the potential to contribute to excessive soft-and hard-tissue destruction. Importantly, triclosan's anti-inflammatory property is effective in abrogating TLR-induced OEC hyperactivity.
A n association between diabetes mellitus and destructive periodontal diseases has been reported in the literature since 1960 (Williams and Mahan, 1960) . A well-described bi-directional relationship between diabetes mellitus and periodontal diseases has been established, whereby diabetes is a major risk factor for periodontitis and the severity of periodontitis influences glycemic control (Preshaw et al., 2012) . In addition, it has been suggested that controlling periodontal inflammation has the potential to reduce the systemic inflammation responsible for secondary complications of diabetes (Preshaw et al., 2012) .
Periodontal diseases are microbially induced inflammatory disorders (Pihlstrom et al., 2005) . Multiple reports have concluded that the nature of the bacterial challenge in patients with diabetes mellitus and periodontitis does not seem to differ from that of individuals without diabetes mellitus (Lalla et al., 2006; Lalla and Papapanou, 2011) . Thus, it seems that the host response to the bacterial challenge is what drives the enhanced severity of periodontal disease in patients with diabetes. In type 1 diabetes (T1D), a hyper-inflammatory monocytic phenotype characterized by enhanced concentrations of proinflammatory mediators following challenge with lipopolysaccharide (LPS) has been implicated as a mechanism of exacerbated tissue destruction (Lalla and Papapanou, 2011) .
Toll-like receptors (TLRs) respond to various pathogen-associated molecular patterns (PAMPs). TLRs are predominantly expressed in cells of the innate immune system (Hans and Hans, 2011) . Research has established that TLRs are also expressed in periodontal tissues on non-hematopoietic immune cells such as epithelial cells (Kusumoto et al., 2004) . TLR responses of oral epithelial cells (OEC) are the first line of defense against potential infectious pathogens within the oral cavity. However, under steady-state conditions, activation of TLRs by commensal bacteria is critical for the maintenance of oral health (Hatakeyama et al., 2003) . Thus, TLR-induced signaling in OECs results in divergent cellular outcomes, which can be a 'two-edged-sword'. Over-production of pro-inflammatory cytokines by OECs, due either to chronic stimulation or inappropriate TLR-responsiveness, can lead to exacerbated soft-and hard-tissue destruction. TLR-responsiveness can be controlled by microRNAs (miRNAs) through their regulation of important intermediate molecules of the signaling cascade. miRNAs are short non-coding RNAs which have emerged as key regulators of gene expression acting at the posttranscriptional level (Filipowicz et al., 2008) . The objective of this study was to evaluate the TLR-responsiveness of OECs derived from participants with T1D and to define mechanisms associated with aberrant responsiveness.
A treatment regimen which is directed at microbial colonization as well as the restoration of proper innate immunity would be beneficial for the treatment of periodontal disease in patients with T1D. 2,4,4-trichloro-2-hydroxydiphenyl ether (triclosan) is a bisphenolic and non-cationic agent used in oral care products because of broadspectrum anti-microbial and anti-plaque activity (Blinkhorn et al., 2009) . We have previously published that pre-treatment of OECs with triclosan can inhibit TLR-induced inflammatory responses (Wallet et al., 2013) . Here, the effects and mechanism(s) of the action of triclosan on TLR-hyper-responsiveness in OECs derived from patients with T1D were explored.
MAtErIALs & MEtHODs

Participant cohorts
The institutional review board (IRB) for the protection of human subjects at the University of Florida approved this protocol. Twenty participants [diabetes-free or diagnosed with type 1 diabetes (T1D)] were recruited from the University of Florida, College of Dentistry, Department of Periodontology and/or Department of Orthodontics. Inclusion criteria were that they were 13 to 75 yrs old, required at least one premolar tooth extraction, or needed surgical treatment. Exclusion criteria were that they had clinically significant neurological, hepatic, renal, gastrointestinal, hematologic, dermatologic, metabolic, autoimmune, or immune deficiency diseases (other than T1D); were receiving any immunosuppressive medication, or antibiotic or glucocorticoid therapy; smoked or used oral tobacco; were pregnant or lactating; were taking medications known to affect the gingival; or had obvious gingival inflammation. There was no significant difference in the average age of diabetes-free (17.11 ± 1.47 yrs) and T1D (18.33 ± 6.31) participants. All T1D participants were under good glycemic control (HBA1c = 7.07 ± 0.40), with an average length of disease of 6.00 yrs (± 5.79). All data are reported as average ± standard deviation (SD).
cell culture
Tissue harvest for OEC culture was performed during third molar extractions, where soft tissues (1 mm waste) associated with the extraction were collected, and epithelial cells were isolated and expanded as previously described (Amir et al., 2011) . The buffy coat was separated by centrifugation (300 x g for 15 min) from 10 mL of heparinized blood. CD14+ cells were sorted by magnetic bead separation (Miltenyi Biotech, Auburn, CA, USA). Purified cells were cultured with 1 ng/mL of M-CSF (Sigma-Aldrich, St. Louis, MO, USA) for 7 days to differentiate monocyte-derived macrophages (Mϕ) as previously described (Lamont et al., 1995; Wallet et al., 2010) . OECs were cultured in a serum-free HEPES and bicarbonate buffered keratinocyte medium (KM) (ScienCell Research Labs, Carlsbad, CA, USA). Mϕ were cultured in DMEM complete media [10% human serum, 0.005% β-2 mercaptoethanol, and 1% penicillin/ streptomycin (Fisher Scientific, Pittsburgh, PA, USA)].
A 1 x 10 6 quantity of OECs, the OECs derived from T1D participants (dOECs), or Mϕ were left untreated or stimulated with 100 ng/mL of agonist [TLR2 (P. gingivalis LPS), TLR4 (E. coli LPS), TLR2/1 (Pam3CKS4), and TLR2/6 (FSL-1)] (InVivogen, San Diego, CA, USA). In some experiments, OECs and dOECs were left untreated or were stimulated following 24-hour pretreatment of 0.75 μg/mL of triclosan (Sigma-Aldrich, St. Louis, MO, USA). Zero, 6, and 24 hrs post-stimulation, culture supernatants and mRNAs were collected for analysis. All assays were performed with 10 donors using primary cells passaged fewer than 5 times.
Immunohistochemistry
OECs were grown on glass coverslips, fixed with 4% PFA, permeabilized with 0.1% triton-X, probed with human antipancytokeratin conjugated to FITC (1:200), and mounted with a DAPI-containing mounting medium. Images were acquired by spinning-disk confocal microscopy.
Flow cytometry
Cells were allowed to dissociate from the bottoms of UpCell (ThermoFisherScientific, Pittsburgh, PA, USA) coated plates. Suspended cells were washed with FACS Buffer (1x PBS + 5% FBS + 0.372 g EDTA) and probed with human anti-pancytokeratin conjugated to FITC (1:200). Cells were acquired on a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) and analyzed with FCS Express (De Novo Software, Los Angeles, CA, USA).
soluble Factors
Human Cytokine ELISA kits (Millipore, Billerica, MA, USA) were used to quantify interleukin-8 (IL-8) and transforming growth factor beta 1 (TGF-β1) in culture supernatants, according to manufacturer's instructions. Concentrations were determined by spectrophotometry with standard curves.
real-time Pcr (qPcr)
Total RNA was harvested with an RNAeasy extraction kit (Qiagen, Valencia, CA, USA). RNA was reverse-transcribed to generate cDNA. Primers specific for GAPDH (Integrated DNA Technologies, Coralville, IA, USA) or hTLR-1, hTLR-2, hTLR-4, and hTLR-6 RT 2 qPCR primers (SABiosciences, Frederick, MD, USA) and Cyber Green 2x Master Mix (BioRad, Hercules, CA, USA) were used for qPCR reactions. Standard curves were used to determine mRNA transcript copy number.
Similarly, total RNA, TaqMan MicroRNA Reverse Transcription Universal PCR Master Mix (Applied Biosystems, Foster City, CA, USA), and miR146a or miR155 primers (Applied Biosystems) were used for miRNA qRT-PCR analysis. miRNA expression values were expressed as fold change over miR146a expression in unstimulated cells at 0 hrs.
statistics
Statistical analyses were performed with GraphPad Software (GraphPad Software Inc., La Jolla, CA, USA), where one-way analysis of variance (ANOVA) with Bonferroni's multiplecomparisons test was used to determine significance (p < .05 was considered significant). All error bars represent standard deviation (SD).
rEsuLts unique tLr-responsiveness by Human OEcs
Primary OECs were isolated, expanded, and characterized ( Fig. 1) . Cells exhibited epithelial cell morphology where 100% of the cells were pancytokeratin-positive (Figs. 1a, 1b) . Others have detected the expression of multiple TLRs in both Mϕ and OECs, although the relative levels of expression have never been described (Mahanonda and Pichyangkul, 2007) . Thus, the mRNA transcript numbers of TLRs 1, 2, 4, and 6 were determined by qPCR in Mϕ and OECs from the same donors ( Fig. 1c ). While both OECs and Mϕ express mRNA for TLRs 1, 2, 4, and 6, OECs express significantly fewer copies of tlr1, tlr2, and tlr4 (Fig. 1c ). While Mϕ express more copies of tlr4 than tlr2, OECs express more copies of tlr2 than tlr4 (Fig. 1c) .
The unique functions of Mϕ and OECs suggest that cellular outcomes following TLR ligation may be divergent. Thus, Mϕ and OECs were stimulated with TLR ligands, and the expression of IL-8 and TGF-β1 was evaluated. All ligands induced IL-8 but not TGF-β1 expression in Mϕ (Figs. 1d, 1e) . Similarly, E. coli LPS, Pam3CKS4, and FSL-1 stimulation induced IL-8 expression by OECs, albeit at significantly lower concentrations than observed in Mϕ (Fig. 1d ). Interestingly, P. gingivalis LPS induced not IL-8 but rather TGF-β1 expression in OECs, a phenotype which was not observed in Mϕ (Figs. 1d, 1e ). type 1 Diabetes-derived OEcs are tLr-hyper-responsive Although monocytic TLR-hyper-responsiveness has been welldescribed in T1D, the TLR-responsiveness of OECs has not. OECs derived from participants with T1D (dOECs) and diabetesfree participants were stimulated with the indicated TLR ligands, and the induction of IL-8 and TGF-β1 was evaluated. Significantly higher concentrations of IL-8 were induced in dOECs when compared with OECs regardless of the ligand utilized ( Fig. 2a ). In addition, P. gingivalis LPS induced significantly higher concentrations of IL-8 along with significantly lower concentrations of TGF-β1 expression in dOECs, when compared with those isolated from diabetes-free participants (Figs. 2a, 2b ).
MicrornA regulation of OEc tLr-responsiveness miR146a and miR155 have been implicated in the negative and positive regulation of TLR signaling, respectively (Taganov et al., 2006) . Therefore, to investigate the mechanism(s) associated with the unique responsiveness of OECs to P. gingivalis LPS, the expression of miR146a and miR155 was evaluated following stimulation with E. coli or P. gingivalis LPS. E. coli LPS stimulation of OECs induced peak expression of miR146a at 24 hrs, while significant induction of miR155 could be observed as early as 6 hrs (Figs. 2c, 2d , black bars). Following stimulation with P. gingivalis LPS, peak induction of miR146a was again observed at 24 hrs, although expression of miR146a could be observed as early as 6 hrs, while induction of miR155 was almost non-existent at both 6 and 24 hrs post-stimulation ( Figs. 2c, 2d , black bars).
Dysregulation of mirnA Expression in t1D-derived OEcs
To investigate the mechanism(s) associated with dOEC TLRhyper-responsiveness, the expression of miR146a and miR155 was again evaluated by qPCR 6 and 24 hrs following stimulation with E. coli or P. gingivalis LPS. Following stimulation of dOECs with E. coli LPS, little miR146a was induced at 6 or 24 hrs post-stimulation, whereby levels were significantly lower than those observed in OECs derived from diabetes-free participants (Fig. 2c, gray bars) . Conversely, significant amounts of miR155 were induced both 6 and 24 hrs post-stimulation, whereby levels at 6 hrs were significantly higher than in OECs (Fig. 2d , gray bars). Following stimulation with P. gingivalis LPS, again, little OEC. ^p < .05 tlr2 vs. tlr4 and tlr6 vs. tlr4. One-way ANOVA with Bonferroni's multiplecomparisons correction. All assays were performed on 10 separate donors and thus represent 10 biological replicates. (d,e) 1 x 10 6 primary human Mϕ (white) and OECs (black) from diabetes-free individuals were left unstimulated or were stimulated for 24 hrs with 100 ng/mL of indicated ligands, after which the supernatants were used to quantify (d) IL-8 and (e) TGF-β1 expression. Data are expressed as pg/mL ± standard deviation. *p < .05. One-way ANOVA with Bonferroni's multiple-comparisons correction. All assays were performed on 10 separate donors.
miR146a was induced at either 6 or 24 hrs post-stimulation, which was accompanied by significant amounts of miR155, which, again, were higher than those observed in OECs (Figs. 2c, 2d, gray bars).
triclosan restores tLr-responsiveness of t1D-derived OEcs through the regulation of mirnA
We have previously published that triclosan can also act as an anti-inflammatory agent on epithelial cells through modulation of miR146 expression (Wallet et al., 2013) . Therefore, to determine if triclosan can ameliorate TLR-hyper-responsiveness of dOECs, cells were pre-treated with triclosan 24 hrs prior to TLR stimulation. As previously demonstrated, triclosan significantly reduced the expression of IL-8 regardless of the ligand utilized, but had no effect on the expression of TGF-β1 following stimulation with P. gingivalis LPS (Figs. 3a, 3b) (Wallet et al., 2013) . Importantly, pre-treatment of dOECs with triclosan resulted in significant reductions in IL-8 expression and was able to restore TGF-β1 expression following stimulation with P. gingivalis LPS (Figs. 3c, 3d) .
Pre-treatment with triclosan also resulted in an increase of miR146a induction in dOECs, restoring peak induction at 24 hrs following stimulation with E. coli LPS and P. gingivalis LPS (Fig. 3e) . In addition, triclosan concomitantly inhibited induction of miR155 in dOECs following stimulation with either E. coli LPS or P. gingivalis LPS (Fig. 3f ).
DIscussIOn
Oral epithelial cells function as nonhematopoietic innate immune cells that contribute directly to innate immunity and play an important role in mucosal homeostasis. Here we demonstrate that while the repertoire of TLRs expressed by OECs is similar to that expressed by Mϕ, the relative amounts and ratios are significantly different. The expression levels and locations of TLR expression on the epithelium have been suggested as mechanisms to regulate inflammatory responses at the mucosal surface (Wells et al., 2010) . Here we demonstrate that, in OECs, along with a differential expression of TLRs was a similar yet attenuated TLR response profile when compared with Mϕ for most ligands tested, whereby OECs also had a unique response to P. gingivalis LPS when compared with Mϕ. Whether this is an effect of the relative ratio of expression or differential localization of the TLRs was not evaluated.
Over-activation of innate immunity or disruption of this homeostasis can result in initiation and/or exacerbation of localized inflammation as seen in periodontal disease associated with T1D. Here we demonstrate that dOECs are hyper-responsive to TLR ligation, as has been observed in T1D-derived monocytes (Poligone et al., 2002; Sen et al., 2003) . The exacerbated TLR-induced inflammatory response from dOECs is concomitant with an absence of TLR-induced regulatory or homeostatic responsiveness. Specifically, significantly higher concentrations of IL-8 are induced in response to P. gingivalis and E. coli LPS in T1D. IL-8 has significant pleiotropic activities, where IL-8 causes an increase in: (1) the release of enzymes from granules, (2) the metabolism of reactive oxygen species (ROS), and (3) the chemotaxis and retention of immune cells, all of which can amplify the inflammatory cascade (Rosenkilde and Schwartz, 2004) . Importantly, IL-8 can also induce osteoclastogenesis and osteoclast activation (Bendre et al., 2003) . Thus, overexpression of IL-8 as seen in T1D-derived OECs can contribute to the exacerbation of both soft-and hard-tissue destruction observed in T1D-associated periodontal disease.
Conversely, P. gingivalis LPS-induced TGF-β1 expression was abrogated in T1D. TGFβ suppresses cell activation and deactivates many innate immune cells, thus preventing the induction of adaptive immunity. Specifically, TGFβ suppresses the expression of MHC II and the production of IL1, IL6, and TNFα, along with inhibition of the proliferation of most adaptive immune cells (Letterio and Roberts, 1998) . TGFβ can also induce the synthesis of bone matrix proteins in osteoblasts as well as most major extracellular matrix proteins (Letterio and Roberts, 1998) . Thus, the absence of TGFβ induction in T1D prevents the control of inflammation and progression of wound healing necessary for the control of periodontal disease.
miRNAs, short non-coding RNA, have emerged recently as key regulators of gene expression acting at the posttranscriptional level (Filipowicz et al., 2008) . miR-146a and miR-155 are important for the regulation of the activation of TLR pathways in myeloid cells (Hou et al., 2009; Ruggiero et al., 2009) . As previously mentioned, the unique purposes of Mϕ and OECs suggest that regulation of their TLR signaling may be divergent. Here we demonstrate that miR146a and miR155 play a regulator role in the unique responsiveness of OECs to P. gingivalis LPS, whereby this level of regulation is disrupted in T1D, directly contributing to exacerbated proinflammatory cytokine expression.
We have previously established that triclosan can modulate TLR-signaling through effects on miR146a expression (Wallet et al., 2013) . Here we confirm that triclosan can modulate miR146a expression and expand its effects to the modulation of miR155. The triclosan/ copolymer, which is used in toothpastes and mouthwashes, has demonstrated a therapeutic effect beyond conventional periodontal therapy (Blinkhorn et al., 2009) , whereby twice-daily use of triclosan significantly improves clinical plaque control and slows periodontal disease progression (Cullinan et al., 2003) . Here we demonstrate a potential mechanism whereby triclosan prevents TLR-induced hyper-responsiveness of T1D-derived OECs by inducing miRNA regulation of the TLR signaling pathway.
We have demonstrated a TLR hyper-responsiveness in T1Dderived OECs along with mechanisms that could explain the exacerbated clinical presentation of periodontal disease in diabetes.
In addition, we have demonstrated that an anti-inflammatory agent, triclosan, can (1) inhibit this TLR-induced hyper-responsiveness and (2) affect miRNA expression, which is appreciated to be involved in the regulation of TLR signaling (Nahid et al., 2009) . Whether these phenomena are linked is still under investigation. Analysis of these data will now direct the investigation into novel accessible targets for personalized intervention in periodontal patients with T1D.
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